CellionBioMed

CellionBioMed is developing several first-class drug candidates for the treatment of incurable diseases such as cirrhosis, pulmonary arterial hypertension, autoimmune diseases, and other untreatable conditions. The company is also working on a new therapy targeting various fibrotic diseases, including idiopathic pulmonary fibrosis (IPF).